DFS Statistics

Total Valuation

ESSA Pharma has a market cap or net worth of $83.36 million. The enterprise value is -$30.24 million.

Market Cap	83.36M
Enterprise Value	-30.24M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ESSA Pharma has 44.34 million shares outstanding. The number of shares has increased by 0.54% in one year.

Current Share Class	44.34M
Shares Outstanding	44.34M
Shares Change (YoY)	+0.54%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	37.12%
Float	26.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.73
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 67.17, with a Debt / Equity ratio of 0.00.

Current Ratio	67.17
Quick Ratio	66.65
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -23.07% and return on invested capital (ROIC) is -16.86%.

Return on Equity (ROE)	-23.07%
Return on Assets (ROA)	-16.48%
Return on Invested Capital (ROIC)	-16.86%
Return on Capital Employed (ROCE)	-29.37%
Revenue Per Employee	n/a
Profits Per Employee	-$814,162
Employee Count	35
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.67% in the last 52 weeks. The beta is 1.56, so ESSA Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-64.67%
50-Day Moving Average	1.75
200-Day Moving Average	1.99
Relative Strength Index (RSI)	65.24
Average Volume (20 Days)	483,679

Short Selling Information

Short Interest	685,653
Short Previous Month	747,957
Short % of Shares Out	1.98%
Short % of Float	n/a
Short Ratio (days to cover)	2.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.40M
Pretax Income	-27.67M
Net Income	-28.50M
EBITDA	n/a
EBIT	-33.40M
Earnings Per Share (EPS)	-$0.64

Full Income Statement

Balance Sheet

The company has $113.87 million in cash and $280,201 in debt, giving a net cash position of $113.59 million or $2.56 per share.

Cash & Cash Equivalents	113.87M
Total Debt	280,201
Net Cash	113.59M
Net Cash Per Share	$2.56
Equity (Book Value)	113.55M
Book Value Per Share	2.56
Working Capital	113.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.43M
Capital Expenditures	n/a
Free Cash Flow	-22.43M
FCF Per Share	-$0.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESSA Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.54%
Shareholder Yield	-0.54%
Earnings Yield	-34.19%
FCF Yield	-26.91%

Analyst Forecast

The average price target for ESSA Pharma is $2.00, which is 5.82% higher than the current price. The consensus rating is "Hold".

Price Target	$2.00
Price Target Difference	5.82%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 25, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 25, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2